Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001104659-22-030009

Chief Operating Officer acquired 11,263 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Dowden Nathan J · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-01 Grant or award : show line 1 in the form +11,263 72,607 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-01 Grant or award : show line 2 in the form Stock Option (Right to Buy) +67,575 67,575 D
Loading xslF345X03/tm228284-5_4seq1.xml…